Phase 1 brings qEEG reports and approved Neuromodulation Studio templates into a clinician-reviewed workflow, supported by patients, scheduling, inbox and evidence.
Verified clinic beta. Each clinical report remains subject to its readiness, consent and release gates. The wider product map below includes preview capabilities.
Decision support—not autonomous diagnosis or treatment.
LIVING CLINICAL INTELLIGENCE
Mental Health & Neuromodulation NERVE
Many signals. A connected clinical picture.
Current focus Future concepts
Zoom into Twins, analyzers and individual data fields
Explore the connections behind clinical decisions.
Ask in plain language and get answers from 186,143 indexed papers, with every study linked to its source. Classified by Jev, our research AI, and always labelled as advisory.
Papers tagged to each curated protocol indication in the v6 corpus, captured 2026-09-25. Counts describe how much has been published, not how well a treatment works. A dot means no tagged protocol yet, not “no evidence”. Select a number to open its evidence map.
Counts from the DeepSynaps evidence database, with the corpus date shown alongside them.
Backend snapshot
186,133Indexed papersRecords in the evidence corpus2,297Clinical trial recordsIndexed ClinicalTrials.gov records348FDA device recordsRegulatory records in the corpus84,347Papers with abstracts45.3% of indexed papers
Snapshot totals are shown until the backend can be verified.
Explore the original product snapshot Product snapshot · 2026-04-24
Explore the product snapshot
These filters explore the bundled modality and condition matrix. They do not query the backend corpus.
Original snapshot totals and scope
These original product-snapshot totals use different scopes and have not been independently reconciled. The year series, modality totals and matrix are separate views; filters do not change these headline counts. They are not verified live corpus totals.
Directory links open each service. They are not citations for the selected matrix entry. The product snapshot lists 10 source families: PubMed, OpenAlex, Cochrane, ClinicalTrials.gov, EMBASE, Scopus, PsycINFO, IEEE Xplore, bioRxiv, medRxiv.
Selected published research · separate from registry totals
Go directly to the research.
Two independent publications relevant to the field. They are examples for exploration, not clinical validation of DeepSynaps or sources for the snapshot counts above.
Neuromodulation · 2007
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial
O’Reardon et al. · Biological Psychiatry Randomised trial
An original study comparing active TMS with a sham procedure. Open the publication to inspect the design, measures and limitations.
An electroencephalographic signature predicts antidepressant response in major depression
Wu et al. · Nature Biotechnology EEG model development
Research using resting EEG and antidepressant trial data to investigate response patterns. This is a published research model, separate from DeepSynaps.
Snapshot grades and regulatory notes are historical product data, not current clinical guidance. Consult the original research and current guidance with the responsible clinician.
Evidence, not vanity numbers
A product map you can inspect.
Counts come directly from the public product and evidence registries. Surface availability can vary by deployment.
25
registered analyzer surfaces
22
registry surfaces marked available; not beta approvals
3
surfaces pending infrastructure
22
distinct analyzer modalities
4
connected clinical studios
3
publicly linked evidence sources
The operating model
One connected workflow. Three clear outcomes.
01
See the full picture
Bring brain, behaviour, physiology, labs, medication and outcomes into one reviewable context.
02
Explore possible paths
Use DeepTwin to compare governed scenarios while keeping assumptions and uncertainty visible.
03
Learn safely over time
Use NERVE to connect evidence, provenance, outcomes and clinician review.
See it work
From signal to governed action.
An interactive overview built from the workflows already represented in the product registries. No patient data is shown.
Multimodal intelligence
Turn complex inputs into reviewable clinical context.
Quality checks, modality-specific visualizations, longitudinal comparison and explicit governance stay together in one workflow.
01Data quality
02Analyzer result
03Clinician review
DeepTwin scenarios
Explore possible paths without presenting certainty.
Compare governed scenarios, assumptions and uncertainty before a clinician chooses what belongs in care.
01Current state
02Scenario comparison
03Uncertainty
NERVE feedback loop
Connect evidence, outcomes and provenance over time.
NERVE keeps feedback visible and reviewable so learning remains traceable rather than silently changing clinical output.
01Evidence trace
02Outcome signal
03Approval gate
Four connected workspaces
Studios built around real clinical work.
Four connected areas for clinical work, with shared patient context and clinician review. Neuromodulation leads the clinical beta; the other Studios remain previews with access by review.
01
Clinical beta · clinician review
Neuromodulation Studio
Draft · Review · Sign off
Plan TMS, tDCS, tACS and neurofeedback workflows with evidence, safety checks and clinician sign-off.
Care focusTMS · tDCS · tACS · neurofeedbackWorkflowDrafts, safety checks and sign-off
Templates and access are reviewed for each clinic.
Dashboard
Plan
Protocols
Evidence & Handbooks
Records
02
Preview · access by review
Medication Studio
Review · Reconcile · Monitor
Review medication history, interactions, side effects and follow-up in one clinician-led workspace.
Care focusHistory · interactions · follow-upWorkflowMedication review and monitoring
PGx is available only when enabled and consented.
Dashboard
Plan
Evidence
Prescriptions
Twin
03
Preview · access by review
Mental Health Studio
Assess · Review · Support
Bring assessments, therapy plans, safety checks and progress reviews into one connected workspace.
Care focusAssessments · therapy · progressWorkflowSession planning and review
Medication and neuromodulation link to their Studios.
Dashboard
Plan
Evidence
Assessments
Twin
04
Preview · access by review
Rehabilitation Studio
Assess · Review · Progress
Connect functional assessments, exercise plans, home programs and session progress.
Care focusMovement · exercises · home programsWorkflowPlans, sessions and progress
Clinical plans remain subject to review and sign-off.
Dashboard
Plan
Evidence
Assessments
Programs
Explore every signal
See what powers every analysis.
Follow each route from inputs and APIs through analysis methods, evidence resources and the relevant Twin scenario.
25product surfaces4specialist Twins
〽
Product surface available
qEEG Analyzer
qEEG decision-support workstation — band power, asymmetry, coherence, topographic maps, spectral markers, and longitudinal trends. Clinician review required.
Evidence tracePMID · benchmark DOI · pipeline version
Twin & scenario routeNo active Twin scenarioNo active simulation route
◎
Infrastructure pending
MRI Analyzer
AI-assisted imaging intelligence workstation — region summaries, volumetric trends, structural findings, and image quality. Not a radiology report; no autonomous radiology diagnosis.
⇄
mri-analysisREST backend
◫
4 inputsaccepted types
◉
4 viewsvisual outputs
↔
4 linkscross-modal links
Algorithms & analysis methods
Volumetric segmentationICV-normalised z-scoresMONAI model gated
Declared processing statusAtlas registration live · segmentation demo
Infrastructure pending in the product registry. This technical state does not grant clinical beta access.
AI-assisted behavioural and motor intelligence workstation — movement markers, affect/attention markers, and behaviour timelines. Privacy and consent governance mandatory.
qEEG reports are in the phase-one clinical beta. Other surfaces are previews or planned capabilities; expand a card for its technical status and access limits.
For developers & builders
Build clinical intelligence into your own product.
Explore integration capabilities for clinical applications, devices and research workflows. Developer access, environments and credentials are reviewed with each organisation during onboarding.
24
declared analyzer API bases
25
analyzer surfaces in the catalog
3/5
FHIR types mapped in the registry
3.1
OpenAPI document version
In onboarding
Read-only public API
Connect reference and evidence data through six read-only public endpoints. Developer keys do not grant access to patient records or analyzer execution.
OpenAPI 3.1 document
/api/public/v1
Six non-PHI read endpoints
In onboarding
Typed TypeScript client
OpenAPI-generated types support a maintained TypeScript wrapper, with CI drift checks. The client is part of the DeepSynaps codebase; package access is reviewed during onboarding.
@deepsynaps/api-client/public
OpenAPI-generated types
CI drift checks
In onboarding
FHIR & OMOP mapping
The clinician-authenticated integration accepts a resources array and returns an OMOP-oriented transform summary. Its resource registry distinguishes mapped types from planned support.
Clinician authentication
Resource mapping registry
Transform summary
In onboarding
Controlled API access
Public developer access is limited by plan entitlement and read scopes. Clinical workflows use separate permissions, consent and review requirements.
Plan entitlement
Narrow-only read scopes
Non-PHI public data
In onboarding
Scoped API credentials
Manage keys for the public reference and evidence API. Secrets are shown once, stored as hashes and support rotation; access depends on your organisation’s enabled entitlement.
reference:read · evidence:read
Shown once; hash-only storage
Scoped key rotation
In onboarding
Test keys & signed webhooks
Test-key credentials and signed HTTPS deliveries support developer events such as key changes and webhook registration. Pings and delivery logs help verify the connection.
Developer metadata events
HMAC-SHA256 signed deliveries
Test ping + delivery log
Public API request formatScoped developer credentials
Developer keys access read-only reference and evidence services. Patient data, analyzer execution and clinical workflows require separate clinician authentication and permissions.
InteroperabilityFHIR resource coverage
PatientMapped
EncounterMapped
ObservationMapped
DevicePlanned
DiagnosticReportPlanned
Patient, Encounter and Observation are mapped in the product registry. Device and DiagnosticReport remain planned. Deployment support is confirmed during onboarding.
Digital health buildersAdd multimodal analysis and evidence context to an existing clinical product.
Clinic software teamsConnect DeepSynaps to the EHR, scheduling and records systems already in use.
Research groupsRun governed cohort and modality workflows against your own datasets.
Device manufacturersRoute device and wearable signal into a reviewable clinical context.
API access is reviewed per organisation and covered by a data-processing agreement. No package permits autonomous diagnosis or treatment.
The intelligence layer
See every connection. Keep every guardrail.
Select any node to trace how APIs, databases, evidence, analyzers and four specialist Twin routes converge under clinician control.
DeepTwin scenarios — simulation-only trajectory review with assumptions and uncertainty kept visible.NERVE governance loop — outcomes are routed through explicit clinician review and sign-off before patient-facing use.
Evidence, safety and provenance
Trust should be inspectable.
01
Evidence stays attached
Sources, grades, assumptions and update state remain visible alongside decision support.
02
Human review is explicit
Clinical outputs are gated for responsible-clinician review rather than presented as autonomous decisions.
03
Provenance is part of the workflow
Inputs, transformations and approvals are designed to remain traceable over time.
Plans and report allowances load from the governed clinic-plan catalog. Plans and credits are agreed with each clinic during onboarding. Clinical governance never changes by plan.
Loading the current launch offer…
No plan enables autonomous diagnosis or treatment.
Bring the intelligence to your clinic
See DeepSynaps with your workflow in mind.
Talk with the team, explore product fit and request reviewed professional access.